Schedule: Daily subcutaneous injections for 812 weeks (extend to 16 weeks if desired), followed by a 24 week pause to resensitize receptors
The main phenotype of loss-of-function mutations in arGSTs is the decreased content of anthocyanins ( 1 ) 19,20,21,22,23,24,25,26,27,28 and proanthocyanidins 27 , which can be well explained by an incomplete biosynthesis due to the absence of an essential enzyme
18,19 As an anti-ulcer peptidergic agent, BPC 157 is also effective both in the upper and lower gastrointestinal tract and now proven to be safe in inflammatory bowel disease (IBD) in clinical Phase II trials, with no toxicity reported
It anchors the wolverine stack and the glow protocol
NAC is a byproduct of glutathione